The evolution of mRNA vaccines alongside SARS-COV-2

SARS-CoV-2 has mutated and evolved to partially evade the immune response generated from prior vaccination or infection. The development of mRNA technology allows for rapid reprogramming of the coding sequence to modify the immune response mounted by the vaccine. Although the long-term trajectory for vaccination recommendations remain unclear, the advanced mRNA vaccine technology allows for the combination and modulation of the targeted sequence to modify the potency of the immune response.... continue reading.

SARS-CoV-2 evolution and implications for immunity

While COVID-19 is no longer plaguing media outlets, the virus remains a serious threat to human health. Since the discovery of SARS-CoV-2, the virus and its transmissibility evolved. The Omicron variant is the dominant circulating virus that causes COVID-19 in the United States and is capable of evading pre-existing immunity, causing serious public health concern. In fact, the greatest number of COVID-19 related hospitalizations occurred during the first Omicron wave. With high burdens of respiratory syncytial virus (RSV) and influenza this season, it is important to remain vigilant and take steps to prevent severe COVID-19 illness.....continue reading.

Spotlight: Jane Ferguson, Ph.D.

Jane Ferguson Ph.D. is an Associate Professor of Medicine in the Division of Cardiovascular Medicine and an Associate Director of the Vanderbilt Microbiome Innovation Center. Dr. Ferguson completed a BA in Human Genetics at Trinity College Dublin, and a PhD in Nutrigenomics at University College Dublin, Ireland, before moving to Philadelphia for postdoctoral training in Cardiovascular Genomics at the University of Pennsylvania. Dr. Ferguson moved to Nashville to join the faculty at Vanderbilt in October 2014.....Click the image on the left to continue reading.

Leigh Howard, M.D., M.P.H.

Leigh
Howard, M.D., M.P.H.
Assistant Professor of Pediatrics

Leigh Howard, MD, MPH, is an assistant professor of Pediatrics in the Division of Pediatric Infectious Diseases at VUMC and a core faculty member in the Vanderbilt Institute for Global Health. She has extensive experience conducting clinical and observational research and vaccine clinical trials in domestic and international settings.

Her primary research focus is understanding host, environmental, and microbial dynamics associated with acute respiratory illness pathogenesis in children by conducting prospective cohort studies with detailed, longitudinal symptom surveillance and contact network evaluation. Specifically, her work explores the impact of interactions between respiratory viruses and viral interactions with Streptococcus pneumoniae in the pathogenesis of acute respiratory illness, as well as transmission patterns of respiratory viruses, bacteria, and antibiotic resistance markers in Peruvian children and their household contacts.

Publications on PubMed.gov

leigh.howard@vumc.org

acute respiratory illness, pneumonia, respiratory viruses, vaccines, global health